Exomind® delivers ExoTMS™ — a next-generation approach to Transcranial Magnetic Stimulation built for outcomes, not appointments. FDA-cleared for Major Depressive Disorder. Noninvasive. Drug-free. Under 30 minutes.
Cleared for the treatment of Major Depressive Disorder in adults who have not achieved satisfactory improvement from prior antidepressant medication.
Built on the proven science of TMS — re-engineered for precision, comfort, and consistency. Operator-independent delivery ensures reproducible results across every session.
No anesthesia, no recovery time, no hospital admission required. You arrive, complete your session, and return to your day.
Minutes per session
no hospital stay
Treatments to initial results for many patients
Exomind® is a next-generation mental wellness platform built on ExoTMS™ — a proprietary evolution of Transcranial Magnetic Stimulation (TMS), one of the most studied noninvasive brain therapies in modern psychiatry.
TMS uses precisely targeted magnetic pulses to stimulate areas of the brain involved in emotional regulation, cognitive function, and mood. Unlike antidepressant medications, TMS works directly at the neurological level — activating dormant neural pathways and restoring healthy brain activity patterns — without affecting the rest of the body.
ExoTMS™ advances the TMS framework with an operator-independent delivery system, ensuring that every session is precisely consistent — removing variability that can affect outcomes when positioning depends on manual technique.
Focused magnetic pulses are delivered to specific areas of the brain associated with mood regulation and emotional processing.
The magnetic field stimulates neurons in underactive regions of the brain — activating dormant pathways involved in emotional regulation.
With repeated sessions, the brain begins to recalibrate toward healthier patterns of activity — reducing symptoms of depression over time.
Continued treatment strengthens neural connectivity across the networks responsible for self-regulation, motivation, and mood stability.
Exomind® is FDA-cleared for the adjunct treatment of Major Depressive Disorder (MDD) in adults who have not achieved satisfactory improvement from prior antidepressant medication in the current episode.
This clearance reflects the substantial clinical evidence behind TMS and ExoTMS™ as a safe and effective option for patients whose depression has not responded adequately to medication alone.
At Renuvo, all ExoTMS™ treatments are conducted under physician supervision and preceded by a clinical consultation to confirm appropriateness and establish a personalized protocol.
Adjunct treatment of Major Depressive Disorder (MDD) in adults who have not achieved satisfactory improvement from prior antidepressant medication in the current episode.
A clinical consultation with a licensed provider is required to confirm suitability for ExoTMS™. Contraindications include metallic implants near the treatment area. Results may vary. Exomind® is an adjunct therapy and does not replace primary psychiatric care.
ExoTMS™ works through a sequence of complementary neurological effects — each building on the last to support lasting improvement in mood and mental wellness.
Magnetic pulses target specific brain regions — particularly those associated with emotional regulation and reward processing — stimulating neurons that have become underactive in depression. This reawakens neural circuits the brain has stopped using efficiently.
Over successive sessions, targeted stimulation helps restore more balanced activity patterns across brain networks involved in mood, cognition, and self-regulation. The brain is not altered — it is guided back toward its own healthy baseline.
Repeated stimulation strengthens the structural and functional connections between brain regions — a process similar in principle to neuroplasticity achieved through learning. Stronger connectivity supports more stable mood regulation over time.
PBM influences pro-inflammatory cytokines and signaling molecules, helping modulate — rather than simply suppress — the inflammatory response.
Thermal effects from near-infrared wavelengths support vasodilation and improved blood flow to treated areas, enhancing oxygen and nutrient delivery.
Exomind® was designed for patients who want effective results with minimal disruption to their lives. No medications. No side effects that affect the whole body. No time away from work.
ExoTMS™ works entirely through targeted magnetic stimulation — no needles, no sedation, no medications introduced into the body. The treatment is delivered externally, with no incisions and no systemic side effects associated with antidepressants.
Unlike conventional TMS systems where positioning accuracy depends on manual technique, ExoTMS™ is operator-independent — ensuring reproducible, consistent stimulation in every session, regardless of who is in the room.
Sessions are completed in under 30 minutes. No hospital admission, no preparation, no anesthesia. Walk in, complete your treatment, walk out. Designed to fit within a lunch break or morning routine.
Many patients begin to notice meaningful improvement in as few as six sessions. While individual responses vary, ExoTMS™ has demonstrated reliable clinical outcomes — with continued improvement as the course of treatment progresses.
Important: The selection of technology used in your treatment is based on clinical indication, treatment area, and goals. Not all patients receive all systems. Your protocol is individualized following medical evaluation.
ExoTMS™ works entirely through targeted magnetic stimulation — no needles, no sedation, no medications introduced into the body. The treatment is delivered externally, with no incisions and no systemic side effects associated with antidepressants.
Unlike conventional TMS systems where positioning accuracy depends on manual technique, ExoTMS™ is operator-independent — ensuring reproducible, consistent stimulation in every session, regardless of who is in the room.
Sessions are completed in under 30 minutes. No hospital admission, no preparation, no anesthesia. Walk in, complete your treatment, walk out. Designed to fit within a lunch break or morning routine.
Many patients begin to notice meaningful improvement in as few as six sessions. While individual responses vary, ExoTMS™ has demonstrated reliable clinical outcomes — with continued improvement as the course of treatment progresses.
These preparatory steps are designed to optimize internal conditions for recovery and tissue response. They are supportive in nature and are not a guarantee of outcome.
Each Exomind® session is quiet, comfortable, and brief. You remain fully awake and alert throughout. Most patients use the time to relax, listen to music, or simply sit quietly — then return directly to their day when it’s complete.
Sessions are consistently under 30 minutes. No preparation, no recovery, no rescheduling your day around appointments.
You remain fully conscious during treatment. No anesthesia, no sedation. Patients typically feel a gentle tapping sensation on the scalp.
No hospital admission required. You can drive yourself to and from appointments and resume normal activities immediately after each session.
Operator-independent ExoTMS™ delivery ensures precise, reproducible stimulation every time — eliminating the variability that can affect results with manually positioned systems.
Many patients notice changes in as few as six sessions. Improvement typically continues throughout the full treatment course and in the weeks that follow.
Physician-supervised consultation to confirm diagnosis, treatment history, and suitability for ExoTMS™. Contraindications reviewed.
Personalized treatment plan established — session frequency, stimulation parameters, and course length determined based on your clinical profile.
Regular sessions under 30 minutes each, delivered on your agreed schedule. You remain awake and comfortable throughout every session.
Regular check-ins to assess response, adjust protocol if needed, and plan any continuation or maintenance sessions.
At Renuvo, all Exomind® treatments are delivered within a medically supervised framework. Mental health treatment requires clinical judgment — not just technology. Our team ensures every patient is properly screened, monitored throughout their course of treatment, and supported in coordinating with their existing care providers.
All treatment decisions and protocols are reviewed and supervised by a licensed physician.
Full screening consultation required before treatment begins. Contraindications are reviewed systematically.
Regular progress assessments throughout the treatment course to track response and adjust protocol as needed.
We work in coordination with your existing mental health providers, not in isolation from them.
Not all patients are candidates for PBM. Contraindications are reviewed during your initial consultation. Active malignancies, photosensitizing medications, and certain conditions may preclude use.
Exomind® is designed for adults seeking a clinically proven, noninvasive approach to treating depression — particularly those who have not found adequate relief through medication alone. A consultation with our clinical team is the first step in determining whether ExoTMS™ is appropriate for your situation.
Good candidates for Exomind® include:
All suitability determinations are made during your clinical consultation. Your provider will review your full medical history and treatment background before recommending Exomind®.
What patients most often ask before starting Exomind®.
During treatment, most patients feel a gentle tapping or knocking sensation on the scalp where the magnetic coil is positioned. This is normal and expected. The sensation is generally well tolerated. You remain fully awake and alert throughout — no sedation is used.
Each Exomind® session is completed in under 30 minutes. No preparation is required beforehand and there is no recovery time after. You can drive yourself to and from appointments and resume all normal activities immediately.
Your treatment course is personalized during your clinical consultation based on your diagnosis, history, and goals. Many patients begin to notice meaningful improvement in as few as six treatments. Full courses typically involve multiple sessions per week over several weeks. Your provider will establish a schedule suited to your situation.
In many cases, yes. Exomind® is indicated as an adjunct treatment — meaning it is designed to complement existing treatments, including antidepressant medication. Your provider will review your current medications during consultation to confirm there are no interactions or concerns.
TMS has a well-established safety profile developed over decades of clinical use. The most commonly reported side effect is mild scalp discomfort or a headache following the first few sessions, which typically subsides as treatment continues. Because ExoTMS™ acts locally on the brain rather than systemically, it does not carry the body-wide side effects associated with antidepressant medications.
Coverage varies by provider and plan. Our team can help you navigate your options during your consultation. Please contact us for current information about coverage and financing options.
You do not need a referral to schedule a consultation at Renuvo. Our clinical team will conduct the necessary evaluation and, if appropriate, will coordinate with your existing mental health providers throughout your treatment.
Your Exomind® consultation includes a full review of your mental health history, current treatment status, and goals — with a determination of whether ExoTMS™ is the right next step for you. We coordinate with your existing care team so nothing is managed in isolation.
All new patients begin with a clinical evaluation. Physician-supervised. Coordinated with your existing care.
Relax, replenish, and restore with integrative wellness experiences designed for the whole person—body, mind, and intention.
Stay updated with wellness tips, clinic updates, and Renuvo insights.
Copyright © 2026 All Rights Reserved.
